🇬🇧 recombinant human C1 inhibitor in United Kingdom

recombinant human C1 inhibitor (recombinant human C1 inhibitor) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Local brand name: Rhucin
  • Status: approved

recombinant human C1 inhibitor in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United Kingdom

Frequently asked questions

Is recombinant human C1 inhibitor approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for recombinant human C1 inhibitor in United Kingdom?

Pharming Technologies B.V. is the originator. The local marketing authorisation holder may differ — check the official source linked above.